Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma

Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma

BackgroundMatrix metallopeptidase 14 (MMP14) is an important gene in the regulation of T-cell function. However, the correlation between MMP14 expression, prognosis, and immune cell infiltration in diffuse large B-cell lymphoma (DLBCL) remains unclear.MethodsWe investigated the influence of MMP14 on...

Full description

Bibliographic Details
Main Authors: Chengliang Yin, Junyan Zhang, Ming Shen, Zhenyang Gu, Yan Li, Wanguo Xue, Jinlong Shi, Wenrong Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
matrix metallopeptidase 14
diffuse large B-cell lymphoma
immune cell infiltration
prognosis
biomarker
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01520/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01520/full

Similar Items